Participating on the panel "How Micro-Nano Innovation Will Drive Next Generation Healthcare" at Techonomy's CDX Accelerate Health + Wellness Conference in Boston on June 22.
Will talk on new tech at interface of bio, nano & ML/AI to preempt diseases
https://t.co/MtqCpkXJKH
@INanoBio CEO, Bharath Takulapalli @PreemptDisease spoke at the 2022 MEMS & Sensors Technical Congress spotlighting the progress made so far on our novel FENT Nanopore Transistor device for >100x fast DNA sequencing #sequencing#sensors@SEMIconex
#DARPA is supporting @INanoBio's effort to develop a device for analyzing #epigenetic markers to detect exposure to weapons of mass destruction with a $5.4M grant
https://t.co/uQ2pEhVzOj
INanoBio Awarded Up to $5.4 Million to Develop an Epigenetic Sequencer for Detecting WMD Exposures #DARPA#epigenetics#wmd#sequencing https://t.co/FKQNfvP6tB